ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,610Medicare Part D Prescriptions Filled, Including Refills

Rank: 56 out of 546

$463K Total Retail Price of All Prescriptions

Rank: 67 out of 546

339 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 339 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

14% of this provider’s 339 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 5,283 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
CARVEDILOL 370 247 1 56
SIMVASTATIN 330 222 2 2
FUROSEMIDE 293 253 3 5
LISINOPRIL 262 191 4 1
LEVOTHYROXINE SODIUM 229 172 5 3
AMLODIPINE BESYLATE 187 145 6 9
ATORVASTATIN CALCIUM 173 150 7 11
HYDROCODONE-ACETAMINOPHEN 163 121 S3 8 8
HYDROCHLOROTHIAZIDE 155 118 9 7
ZOLPIDEM TARTRATE 144 103 10 26
METFORMIN HCL 129 86 11 10
NEXIUM 126 93 12 52
POTASSIUM CHLORIDE 112 99 13 30
ALLOPURINOL 111 103 14 41
METOPROLOL SUCCINATE 110 92 15 17
PANTOPRAZOLE SODIUM 109 54 16 18
TRAMADOL HCL 101 57 17 19
CITALOPRAM HBR 97 50 18 21
BYSTOLIC 85 79 19 182
ATENOLOL 83 72 20 12
FLUOXETINE HCL 77 34 21 39
WARFARIN SODIUM 76 65 22 13
CLOPIDOGREL 76 64 22 77
OMEPRAZOLE 76 34 22 4
KLOR-CON M20 76 76 22 57
METOPROLOL TARTRATE 75 62 26 6
PROAIR HFA 75 52 26 27
ACETAMINOPHEN-CODEINE 74 42 S3 28 113
DIOVAN 72 72 29 65
AZITHROMYCIN 70 46 30 55
FENTANYL 66 0 S2 31 50
OXYCODONE-ACETAMINOPHEN 65 24 S2 32 54
LIPITOR 61 26 33 80
QUETIAPINE FUMARATE 59 36 34 72
GABAPENTIN 57 52 35 16
CIPROFLOXACIN HCL 55 35 36 84
SERTRALINE HCL 55 28 36 14
CRESTOR 54 32 38 36
CYCLOBENZAPRINE HCL 53 33 R 39 34
RANITIDINE HCL 51 32 40 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 18, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.